Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy
Mycopathologia · 2025
DOI: 10.1007/s11046-025-00997-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Mycopathologia, 2025. Verfasst von Atsuhiko Fukuto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.…. Hauptthemen laut MEDLINE: Antifungal Agents, Ascomycota, Keratitis, Mycoses. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hiroshima University.
Abstract (Originalsprache)
This report describes two cases of Curvularia geniculata keratitis, a rare form of fungal keratitis successfully managed with natamycin-based therapy. Both patients presented with characteristic feathery corneal infiltrates following ocular trauma. In vivo confocal microscopy and direct microscopy revealed septate filamentous fungi, and the isolates were definitively identified as C. geniculata through sequence analysis of the translation elongation factor 1-alpha ( tef1-α ) gene. Antifungal susceptibility testing showed sensitivity to natamycin at 2 μg/mL for both isolates, with variable sensitivity to other antifungal agents. Patient 1 was treated with a combination of topical natamycin and voriconazole, while Patient 2 received natamycin monotherapy. Both patients achieved complete healing and excellent visual outcomes. These cases underscore the importance of accurate molecular identification for species differentiation within the Curvularia genus and demonstrate the efficacy of natamycin-based therapy for C. geniculata keratitis. The choice between monotherapy and combination therapy may be guided by clinical severity and antifungal susceptibility testing. This report contributes to the understanding of the clinical features, diagnosis, and management of this rare condition and highlights the potential value of susceptibility testing in guiding treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan. fukuto@hiroshima-u.ac.jp.
- Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
- Section of Clinical Laboratory, Division of Clinical Support, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
- Division of Laboratory Medicine, Hiroshima University Hospital, Hiroshima, 734-8551, Japan.
- Medical Mycology Research Center, Chiba University, Chiba, 260-8673, Japan.
Förderung
- Hiroshima University
Zitieren
APA
Fukuto, A., Miyako, F., Hara, T., Nagaoka, R., Yaguchi, T., Sakaguchi, H., & Chikama, T. (2025). Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy. Mycopathologia. https://doi.org/10.1007/s11046-025-00997-9
Vancouver
Fukuto A, Miyako F, Hara T, Nagaoka R, Yaguchi T, Sakaguchi H, et al. Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy. Mycopathologia. 2025. doi:10.1007/s11046-025-00997-9
BibTeX
@article{Fukuto2025,
author = {Fukuto, Atsuhiko and Miyako, Fumiya and Hara, Toshinori and Nagaoka, Rie and Yaguchi, Takashi and Sakaguchi, Hirokazu and Chikama, Taiichiro},
title = {Two Cases of Curvularia geniculata Keratitis Successfully Treated with Natamycin-Based Therapy},
journal = {Mycopathologia},
year = {2025},
doi = {10.1007/s11046-025-00997-9}
}
EUVIMED